220 related articles for article (PubMed ID: 9270024)
21. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
22. Id genes encoding inhibitors of transcription are expressed during in vitro astrocyte differentiation and in cell lines derived from astrocytic tumors.
Andres-Barquin PJ; Hernandez MC; Hayes TE; McKay RD; Israel MA
Cancer Res; 1997 Jan; 57(2):215-20. PubMed ID: 9000557
[TBL] [Abstract][Full Text] [Related]
23. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
[TBL] [Abstract][Full Text] [Related]
24. Id gene expression as a key mediator of tumor cell biology.
Israel MA; Hernandez MC; Florio M; Andres-Barquin PJ; Mantani A; Carter JH; Julin CM
Cancer Res; 1999 Apr; 59(7 Suppl):1726s-1730s. PubMed ID: 10197587
[TBL] [Abstract][Full Text] [Related]
25. atonal- and achaete-scute-related genes in the annelid Platynereis dumerilii: insights into the evolution of neural basic-Helix-Loop-Helix genes.
Simionato E; Kerner P; Dray N; Le Gouar M; Ledent V; Arendt D; Vervoort M
BMC Evol Biol; 2008 Jun; 8():170. PubMed ID: 18541016
[TBL] [Abstract][Full Text] [Related]
26. Ubiquilin-1 is a novel HASH-1-complexing protein that regulates levels of neuronal bHLH transcription factors in human neuroblastoma cells.
Persson P; Stockhausen MT; Påhlman S; Axelson H
Int J Oncol; 2004 Nov; 25(5):1213-21. PubMed ID: 15492808
[TBL] [Abstract][Full Text] [Related]
27. Hash4, a novel human achaete-scute homologue found in fetal skin.
Jonsson M; Björntorp Mark E; Brantsing C; Brandner JM; Lindahl A; Asp J
Genomics; 2004 Nov; 84(5):859-66. PubMed ID: 15475265
[TBL] [Abstract][Full Text] [Related]
28. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
29. Distinct patterns of downstream target activation are specified by the helix-loop-helix domain of proneural basic helix-loop-helix transcription factors.
Talikka M; Perez SE; Zimmerman K
Dev Biol; 2002 Jul; 247(1):137-48. PubMed ID: 12074558
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.
de Bont JM; den Boer ML; Kros JM; Passier MM; Reddingius RE; Smitt PA; Luider TM; Pieters R
J Neuropathol Exp Neurol; 2007 Jun; 66(6):505-16. PubMed ID: 17549010
[TBL] [Abstract][Full Text] [Related]
31. [Induction of primitive neuroectodermal tumors by oncogene complementation].
von Deimling A; Aguzzi A; Kleihues P; Land H; Wiestler OD
Verh Dtsch Ges Pathol; 1990; 74():432-6. PubMed ID: 1708633
[TBL] [Abstract][Full Text] [Related]
32. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.
Janss AJ; Yachnis AT; Silber JH; Trojanowski JQ; Lee VM; Sutton LN; Perilongo G; Rorke LB; Phillips PC
Ann Neurol; 1996 Apr; 39(4):481-9. PubMed ID: 8619526
[TBL] [Abstract][Full Text] [Related]
33. Karyotypic evolution pathways in medulloblastoma/primitive neuroectodermal tumor determined with a combination of spectral karyotyping, G-banding, and fluorescence in situ hybridization.
Cohen N; Betts DR; Tavori U; Toren A; Ram T; Constantini S; Grotzer MA; Amariglio N; Rechavi G; Trakhtenbrot L
Cancer Genet Cytogenet; 2004 Feb; 149(1):44-52. PubMed ID: 15104282
[TBL] [Abstract][Full Text] [Related]
34. PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.
Inda MM; Mercapide J; Muñoz J; Coullin P; Danglot G; Tuñon T; Martínez-Peñuela JM; Rivera JM; Burgos JJ; Bernheim A; Castresana JS
Oncol Rep; 2004 Dec; 12(6):1341-7. PubMed ID: 15547761
[TBL] [Abstract][Full Text] [Related]
35. [Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor].
Chang Q; Ng HK
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):24-8. PubMed ID: 17374234
[TBL] [Abstract][Full Text] [Related]
36. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
[TBL] [Abstract][Full Text] [Related]
37. An achaete-scute homologue essential for neuroendocrine differentiation in the lung.
Borges M; Linnoila RI; van de Velde HJ; Chen H; Nelkin BD; Mabry M; Baylin SB; Ball DW
Nature; 1997 Apr; 386(6627):852-5. PubMed ID: 9126746
[TBL] [Abstract][Full Text] [Related]
38. Phylotypic expression of the bHLH genes Neurogenin2, Neurod, and Mash1 in the mouse embryonic forebrain.
Osório J; Mueller T; Rétaux S; Vernier P; Wullimann MF
J Comp Neurol; 2010 Mar; 518(6):851-71. PubMed ID: 20058311
[TBL] [Abstract][Full Text] [Related]
39. Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum").
Herpers MJ; Budka H
Clin Neuropathol; 1985; 4(1):12-8. PubMed ID: 3978900
[TBL] [Abstract][Full Text] [Related]
40. NeuroD2 and neuroD3: distinct expression patterns and transcriptional activation potentials within the neuroD gene family.
McCormick MB; Tamimi RM; Snider L; Asakura A; Bergstrom D; Tapscott SJ
Mol Cell Biol; 1996 Oct; 16(10):5792-800. PubMed ID: 8816493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
